Simple Summary Colorectal cancer remains one of the most significant sources of cancer-
related morbidity and mortality worldwide. The liver is the most common site of metastatic …

Efforts to combat colorectal cancer have benefited from improved screening and
surveillance, which facilitates early detection. The survival rate associated with diagnosis at …

In patients with colorectal cancer (CRC) that metastasizes to the liver, there are several key
goals for improving outcomes including early detection, effective prognostic indicators of …

Simple Summary Colorectal cancer (CRC) is a leading cause of death among cancer
patients, and the liver is the most common visceral metastatic site. Despite promising …

Colorectal liver metastases (CRLM) present an important clinical challenge in both surgical
and medical oncology. Despite improvements in management, survival among patients …

Liver metastases are the most common site of metastatic spread in colorectal cancer.
Current treatment approaches involve effective systemic therapies in combination with …

Surgical resection of the liver is the standard treatment for colorectal liver metastases, but
70% of patients still experience recurrence, resulting in limited survival. Molecular …

Colorectal liver metastases (CRLM) are the leading cause of death among patients with
metastatic colorectal cancer (CRC). As part of multimodal therapy, liver resection is the …

In resectable colorectal liver metastasis (CRLM) the role and use of molecular biomarkers is
still controversial. Several biomarkers have been linked to clinical outcomes in CRLM, but …

BACKGROUND: Determination of prognosis in patients with resectable colorectal liver
metastases (CLM) is desirable in order to improve case selection for surgery and tailor …